D. Serin

1.6k citations
73 papers · 1.2k · h-index 15

Impact in

  • Oncology top 5%
    • Cancer Treatment and Pharmacology
    • HER2/EGFR in Cancer Research
    • Colorectal Cancer Treatments and Studies
    • Breast Cancer Treatment Studies

Papers in

    • Cancer Treatment and Pharmacology 29
    • HER2/EGFR in Cancer Research 6
    • Cancer survivorship and care 6
    • Breast Cancer Treatment Studies 27

D. Serin

67 papers receiving 1.2k citations

Peers

D. Serin
Comparison fields: 5 of 77
  • Oncology 759
  • Cancer Research 375
  • Dermatology 190
  • Genetics 430
  • Public Health, Environmental and Occupational Health 203
Replace H. Hamed with:
H. Hamed United Kingdom
Keren Sturtz United States
Seeyoun Lee South Korea
Francesco Nuzzo Italy
Anne Moore United States
D.F. Easton United Kingdom
Damon Disch United States
Heinz Tüchler Austria
Fentiman Is United Kingdom
Shulamith Rizel Israel
D. Serin relative to H. Hamed United Kingdom H. Hamed's profile →
Citations per field
00.5×3.5×
H. Hamed · 1×
Citations per year

Countries citing papers authored by D. Serin

Since Specialization
Citations

This map shows the geographic impact of D. Serin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Serin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Serin more than expected).

Fields of papers citing papers by D. Serin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Serin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Serin. The network helps show where D. Serin may publish in the future.

Co-authors

The 25 scholars most cited alongside D. Serin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D. Serin Line = papers co-authored together D. Serin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2003247
2 2009125
3 1997119
4 199690
5 200387
6 200648
7 199941
8
Phase II randomized study of paclitaxel versus mitomycin in advanced breast cancer.
199538
9 199632
10 200630
11
[Frequency of lymphedema of the upper limb after treatment of breast cancer. Risk factors. Apropos of 683 cases].
199626
12 200723
13
[Lymphoscintigraphic aspects of the effects of manual lymphatic drainage].
199623
14 199316
15 200414
16 200214
17 201213
18 200711
19 198211
20
Recommandations pour la pratique clinique de Saint-Paul-de-Vence
200511

About D. Serin

D. Serin is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Genetics and General Health Professions, having authored 73 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (29 papers), Breast Cancer Treatment Studies (27 papers), Advanced Breast Cancer Therapies (9 papers), HER2/EGFR in Cancer Research (6 papers), BRCA gene mutations in cancer (6 papers), Estrogen and related hormone effects (6 papers), Cancer survivorship and care (6 papers) and Chemotherapy-related skin toxicity (5 papers). The work is most often cited by research in Oncology (759 citations), Cancer Research (375 citations), Dermatology (190 citations), Genetics (430 citations) and Public Health, Environmental and Occupational Health (203 citations). D. Serin has collaborated with scholars based in France, Belgium and United Kingdom. Frequent co-authors include P. Fumoleau, M. Namer, R. Largillier, B. Audhuy, Jean‐François Morère, Hubert Orfeuvre, Thierry Lesimple, Véronique Dièras, E. Vuillemin and Stéphane Culine. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Cancer Research, Annals of Oncology and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact